Squarepoint’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 3218 |
|
|
2025
Q1 | – | Sell |
-18,332
| Closed | -$17.9K | – | 3229 |
|
|
2024
Q4 | $17.9K | Buy |
+18,332
| New | +$17.9K | ﹤0.01% | 2715 |
|
|
2024
Q2 | – | Sell |
-13,938
| Closed | -$22.9K | – | 2998 |
|
|
2024
Q1 | $22.9K | Buy |
+13,938
| New | +$22.9K | ﹤0.01% | 2362 |
|
|
2022
Q3 | – | Sell |
-1,053
| Closed | -$6K | – | 2538 |
|
|
2022
Q2 | $6K | Buy |
+1,053
| New | +$6K | ﹤0.01% | 2052 |
|
|
2021
Q2 | – | Sell |
-1,475
| Closed | -$88K | – | 3047 |
|
|
2021
Q1 | $88K | Sell |
1,475
-1,485
| -50% | -$88.6K | ﹤0.01% | 2384 |
|
|
2020
Q4 | $155K | Buy |
+2,960
| New | +$155K | ﹤0.01% | 2232 |
|
|
2020
Q3 | – | Sell |
-3,228
| Closed | -$280K | – | 2690 |
|
|
2020
Q2 | $280K | Sell |
3,228
-697
| -18% | -$60.5K | ﹤0.01% | 1596 |
|
|
2020
Q1 | $228K | Sell |
3,925
-1,548
| -28% | -$89.9K | 0.01% | 1409 |
|
|
2019
Q4 | $395K | Buy |
5,473
+4,137
| +310% | +$299K | ﹤0.01% | 1845 |
|
|
2019
Q3 | $82K | Buy |
+1,336
| New | +$82K | ﹤0.01% | 2105 |
|